Graham Capital Management, L.P. Bridge Bio Pharma, Inc. Transaction History
Graham Capital Management, L.P.
- $4.42 Billion
- Q3 2024
A detailed history of Graham Capital Management, L.P. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 32,421 shares of BBIO stock, worth $753,464. This represents 0.02% of its overall portfolio holdings.
Number of Shares
32,421
Previous 16,709
94.03%
Holding current value
$753,464
Previous $423,000
95.04%
% of portfolio
0.02%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding BBIO
# of Institutions
291Shares Held
171MCall Options Held
10.4MPut Options Held
2.37M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$587 Million35.94% of portfolio
-
Viking Global Investors LP25.1MShares$584 Million2.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$330 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$289 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$141 Million63.58% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $3.45B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...